GL1X · GenesisL1 explorer

Research workbench

Blac E166A cdc-1 acyl-intermediate

Analyse Blac E166A cdc-1 acyl-intermediate in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3VFH
Type
protein
Length
1,060 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
P0C5C1
Ligands
CD6, PO4
Pockets
9 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DBeta-lactamase (EC 3.5.2.6)protein26542% helix, 17% strandP0C5C1

Ligands and binding sites

  • CD6 · (2R)-5-methylidene-2-{(1R)-2-oxo-1-[(phenylacetyl)amino]ethyl}-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid · ligand · 2 copies · chains A, B, C, D
  • PO4 · Phosphate ion · ion · 7 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12710.690.8539PO4
21540.690.8930PO4
36010.670.7758CD6
44880.620.7643CD6
52620.520.7549empty

Interfaces

4 interfaces between chains.

  • A–B · 898 Ų buried · 11 hydrogen bonds · protein-protein
  • C–D · 762 Ų buried · 9 hydrogen bonds · protein-protein
  • A–C · 627 Ų buried · 3 hydrogen bonds · protein-protein
  • B–D · 611 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 3VFH · BlaC E166A CDC-1 Acyl-Intermediate · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.